Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 4,778,581 | 4,778,581 | 0 | $165.24M | $151.58M | 60.14% | -$13.67M |
| Cytokinetics, Incorporated(CYTK) | 714,695 | 714,695 | 0 | $60.88M | $47.11M | 18.69% | -$13.78M |
| Relay Therapeutics, Inc.(RLAY) | 1,250,000 | 1,250,000 | 0 | $23.39M | $22.56M | 8.95% | -$825.0K |
| Eikon Therapeutics, Inc.(EIKN) | 1,943,682 | 1,943,682 | 0 | $25.37M | $15.63M | 6.20% | -$9.74M |
| Veracyte, Inc.(VCYT) | 0 | 200,000 | +200,000 | $0 | $9.21M | 3.65% | +$9.21M |
| Xenon Pharmaceuticals Inc.(XENE) | 160,000 | 160,000 | 0 | $9.66M | $5.95M | 2.36% | -$3.71M |
| Crinetics Pharmaceuticals, Inc. | 150,000 | 0 | -150,000 | $5.61M | $0 | — | -$5.61M |